Results
Goldline Pharma FY26 Net Profit Up 45% to ₹4.12 Cr
Goldline Pharmaceutical Limited submitted its Annual Report for FY 2025-26, reporting a 45% increase in net profit to ₹4.12 crore and revenue growth to ₹31.20 crore.
The company successfully listed on
